Quantifying the impact of the COVID-19 pandemic on cancer center clinical trial operations
AbstractBackground. Oncology clinical trials are complex, and the COVID-19 pandemic caused major disruptions in 2020.Methods. Using its networking and shar
AbstractBackground. Oncology clinical trials are complex, and the COVID-19 pandemic caused major disruptions in 2020.Methods. Using its networking and shar
Sotorasib was the first approved KRAS inhibitor granted marketing authorisation by the US Food and Drug administration (FDA) by use of the accelerated approval pathway…
Sequential CD7 CAR T-cell therapy plus haploidentical HSCT without GVHD prophylaxis is effective and safe in CD7-positive hematologic malignancies.
Dr James Shultz, (University of Miami Miller School of Medicine, Miami, USA), Dr Ana Patricia Ortiz (University of Puerto Rico, and University of Puerto Rico…
Hesham Abdullah, MD, MSc, of GSK, discusses myelofibrosis and the uses of momelotinib, also known as Ojjaara, to treat it.
Caribbean small island developing states are becoming increasingly vulnerable to compounding disasters, prominently featuring climate-related hazards and pandemic diseases, which exacerbate existing barriers to cancer…
AbstractAims. Atrial functional mitral regurgitation (AFMR) has been associated with atrial fibrillation (AF) and heart failure with preserved ejection fraction
Peruse the current issue of The Lancet Oncology, a monthly journal covering international issues relevant to clinical cancer specialists worldwide
Abstract. Non-invasive imaging plays an increasingly important role in emergency medicine, given the trend towards smaller, portable ultrasound devices, th
Oncogene – The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia
The abstract submission system is now open